Aquestive Therapeutics



Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117.

Daniel Barber
Peter Boyd
SVP, Business Process & Information Technology
Lori J. Braender
SVP, General Counsel
Mark Lepore
Chief Medical Officer, Allergy
Ken Marshall
SVP, Chief Commercial Officer
Mark Schobel
Chief Innovation & Technology Officer
Gary H. Slatko
SVP, Chief Medical Officer, Neurology
Ernie Toth
Theresa Wood
SVP, Human Resources

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.